The production of the HSP-Ex vaccine is mainly elicited via heat shock treatment of tumor cells to collect and obtain exosomes in the culture medium, after which filtration is performed (such as fractional ultracentrifugation, polymer precipitation and membrane filtration) to efficiently purify the exosomes. This evidence concerns the gene HSP90B2P and neoplasm.